HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators

Mohamed Benchekroun Alejandro Romero Javier Egea Rafael León Patrycja Michalska Izaskun Buendía María Luisa Jimeno Daniel Jun Jana Janockova Vendula Sepsova Ondrej Soukup Oscar Bautista-Aguilera Bernard Refouvelet Olivier Ouari José Marco-Contelles Lhassane Ismaili 1
1 Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive, Université de Bourgogne - Franche-Comté, Besançon, France.
Document type :
Journal articles
Complete list of metadata
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03654706
Contributor : Lhassane Ismaili Connect in order to contact the contributor
Submitted on : Thursday, April 28, 2022 - 5:49:04 PM
Last modification on : Friday, April 29, 2022 - 3:08:36 AM

Identifiers

Collections

UNIV-FCOMTE | UNIV-BOURGOGNE

Citation

Mohamed Benchekroun, Alejandro Romero, Javier Egea, Rafael León, Patrycja Michalska, et al.. The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. Journal of Medicinal Chemistry, American Chemical Society, 2016, 59 (21), pp.9967-9973. ⟨10.1021/acs.jmedchem.6b01178⟩. ⟨hal-03654706⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

0